| 摘要 |
<p>The invention concerns pharmaceutical compositions characterised in that they contain, in association with a pharmaceutically inert carrier, a therapeutically efficient amount of a mixture of farnesol α-bisabolol and/or geraniol and/or derivatives thereof, in particular functional derivatives such as their esters, for example methohexate, their ethers, in particular with hydroxylated compounds such as adriamycin, C1-C4 alkyl ethers, or glycosylated derivatives. The invention is useful in particular for preventing and treating cancers.</p> |
